Tazza Optima Sanitizing Wipes
- Manufacturer
- Tazza Brands East Inc.
- Effective date
- 2024-02-20
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 00:09:41
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
Drug Facts
OTC - ACTIVE INGREDIENT SECTION
Active ingredient
Benzalkonium Chloride 0.13%
OTC - PURPOSE SECTION
Purpose
Antiseptic
INDICATIONS & USAGE SECTION
Uses
- to decrease bacteria on the skin
- recommended for repeated use
WARNINGS SECTION
Warnings
For external use only
OTC - WHEN USING SECTION
When using this product keep away from eyes. In case of eye contact, rinse eyes with water.
OTC - STOP USE SECTION
Stop use and ask a doctor if irritation or redness develop or last more than 72 hours.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center immediately.
DOSAGE & ADMINISTRATION SECTION
Directions
- rub wipe thoroughly over all surfaces of both hands
- allow to dry without wiping
- supervise children under 6 years old
- not recommended for infants
- dispose of wipe in trash, do not flush
INACTIVE INGREDIENT SECTION
Inactive ingredients Aloe Barbadensis Leaf Juice, Decyl Glucoside, Glycerin, Purified Water.
SPL UNCLASSIFIED SECTION
Manufactured for Terraboost Media, LLC
3109 Grand Avenue #300
Miami, FL 33133
A Product of Terraboost ®
877-837-7210 •
www.tazzabrands.com
Made in China
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
tazza ®
Antiseptic
OPTIMA SANITIZING WIPE
Contains Benzalkonium Chloride
Alcohol-Free Formula
Kills Germs
1460 Wet Wipes
3.54 in. x 7.09 in. (9cm x 18cm)
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1038558 | benzalkonium chloride 0.13 % Medicated Pad | PSN | 1 |
| 1038558 | benzalkonium chloride 1.3 MG/ML Medicated Pad | SCD | 1 |
| 1038558 | benzalkonium chloride 0.13 % Topical Cloth | SY | 1 |
| 1038558 | benzalkonium chloride 0.13 % Topical Swab | SY | 1 |
| 1038558 | benzalkonium chloride 0.13 GM per 100 GM Topical Pad | SY | 1 |
| 1038558 | benzalkonium chloride 0.13 GM per 100 GM Topical Swab | SY | 1 |
| 1038558 | benzalkonium chloride 1 ML per 750 ML Topical Swab | SY | 1 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 76370-0023-1 | Tazza Optima Sanitizing Wipes | 1.3 mL in 1 APPLICATOR | CLOTH | 1.3 | 1 | |
| 76370-0023-1 | Tazza Optima Sanitizing Wipes | 1460 in 1 BAG | CLOTH | 1460 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 76370-0023 | TAZZA OPTIMA SANITIZING WIPES (BENZALKONIUM CHLORIDE) CLOTH [TAZZA BRANDS EAST INC.] | 1 | 2 package rows | 20240314_136c9ebe-f794-c086-e063-6294a90aef87.zip |
Products#
Every source-derived product name is available through these pages.
- Tazza Optima Sanitizing Wipes
- Benzalkonium Chloride
- GLYCERIN
- WATER
- ALOE VERA LEAF
- BENZALKONIUM
- DECYL GLUCOSIDE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 76370-0023 | 76370-0023-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| GLYCERIN | PDC6A3C0OX | IACT |
| WATER | 059QF0KO0R | IACT |
| ALOE VERA LEAF | ZY81Z83H0X | IACT |
| BENZALKONIUM CHLORIDE | F5UM2KM3W7 | ACTIB |
| DECYL GLUCOSIDE | Z17H97EA6Y | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 136cde58-7387-db3a-e063-6294a90a9c9c | 136c9ebe-f794-c086-e063-6294a90aef87 | 2024-02-20 | Warnings | 136cde58-7387-db3a-e063-6294a90a9c9c 136c9ebe-f794-c086-e063-6294a90aef87 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.

